Aktis Oncology seeks $945 million valuation, secures Lilly as IPO anchor investor - Reuters

Reuters | Jan. 7, 2026, 8:20 a.m. | Original
Aktis Oncology seeks $945 million valuation, secures Lilly as IPO anchor investor Reuters
UniFirst's Q1 revenue slightly beats estimates - TradingView — Track All Markets Power restored in Berlin after longest blackout since World War Two - Reuters